This study aims to understand the state of onset of NLSD(neutral lipid storage disease) / TGCV(triglyceride deposit cardiovasculopathy) worldwide, background information of affected patients, and natural history of the disease, as well as exploring the prognostic factors and assessing the efficacy of disease-specific treatment.
Patients who are diagnosed with NLSD / TGCV
None
Patients who are diagnosed with NLSD /TGCV (including adults only)
Cohort
Other
Not listed
Period from the diagnosis of NLSD / TGCV to death from any cause
This is the period from the date of diagnosis of NLSD / TGCV to the date of death from any cause. The last date of confirmation of survival will be used as the cut-off date for living patients and patients who are lost to follow-up.
Serum CK(Creatine Kinase) level
Evaluating the serum CK level by measuring
Serum BNP(B-type Natriuretic Peptide) level
Evaluating serum BNP level by measuring
Serum AST(Aspartate transaminase) level
Evaluating serum AST level by measuring
Serum ALT(Alanine transaminase) level
Evaluating serum ALT level by measuring
Click on the lead sponsor to view all of their trials.
